Tesamorelin Mixing & Dosage Protocols

Tesamorelin (10 mg) — Research Dosage Guidance
Reconstitution (Mixing)

  • Add 2 ml Bacteriostatic Water to the vial
  • Roll gently between palms (do not shake)
  • Store reconstituted vial in the refrigerator (2–8 °C)

Concentration Calculation

10 mg ÷ 2 ml = 5 mg per ml

Every 10 insulin units (0.1 ml) = 0.5 mg (500 mcg)

Core Dosage Guidelines

For fat-loss, body-composition improvement, and growth-hormone stimulation research

Standard research protocol: 1 mg daily

Timing: Inject once daily, preferably at night before sleep, on an empty stomach (≥2 hours after food)

Alternate schedule: Every other day or 5 days per week for maintenance

Administration: Subcutaneous injection (abdomen or thigh)

Injection sites: Rotate regularly

Syringe Measurement Guide
Dose    Volume (ml)    Insulin Units
250 mcg    0.05 ml    5 units
500 mcg    0.10 ml    10 units
1 mg (recommended)    0.20 ml    20 units

Reference: Every 10 units (0.1 ml) = 500 mcg Tesamorelin

Targeted Research Protocols (Different Situations)
1.⁠ ⁠Abdominal / Visceral Fat Reduction Research

  • (Central fat, metabolic optimization models)
  • Dose: 1 mg
  • Frequency: Once daily
  • Timing: Nighttime (pre-sleep)
  • Duration: 8–12 weeks
  • Notes: Best-studied use case for Tesamorelin

2.⁠ ⁠Body Recomposition & Lean-Mass Preservation

  • (Fat loss with muscle preservation)
  • Dose: 1 mg
  • Frequency: 5–7× weekly
  • Duration: 10–12 weeks
  • Notes: Maintain adequate protein intake in research models

3.⁠ ⁠Growth Hormone & IGF-1 Pathway Research

  • (GH pulse amplification, recovery models)
  • Dose: 500 mcg – 1 mg
  • Frequency: Once daily
  • Timing: Evening or pre-sleep
  • Duration: 8–12 weeks
  • Notes: Lower doses may still produce measurable GH effects

4.⁠ ⁠Recovery, Sleep & Skin-Health Research

  • (Tissue repair, sleep architecture, dermal quality)
  • Dose: 500 mcg – 1 mg
  • Frequency: 3–5× weekly
  • Timing: Nighttime preferred
  • Duration: 6–10 weeks
  • Notes: Reduced frequency often sufficient

5.⁠ ⁠Maintenance / Long-Term Support Research

  • Dose: 500 mcg
  • Frequency: Every other day or 3× weekly
  • Duration: Ongoing after a full cycle
  • Notes: Helps sustain GH support with reduced exposure

Cycle Duration

  • Typical cycle: 8–12 weeks
  • Maintenance phase: 500 mcg daily or every other day
  • Breaks: Recommended between extended research cycles

Key Research Benefits

  • Promotes endogenous growth-hormone release
  • Supports IGF-1 production
  • Encourages fat loss, especially abdominal fat
  • Assists muscle definition and recovery
  • May enhance sleep quality and skin health

Important Notes

Always use sterile needles and alcohol swabs

Do not reuse or share needles

Store reconstituted peptide at 2–8 °C

For research use only